J Clin Endocrinol Metab 95(2):872878 Cervera A, Wajcberg E, Sriwijitkamol A, Fernandez M, Zuo P, Triplitt C et al (2008) Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes
Testing is performed for heavy metals, microbes, disintegration, potency, and quantity of active ingredients in the finished product
The warning directs health care professionals to evaluate baseline vitamin B6 levels prior to starting patients on treatment with carbidopa/levodopa therapies and periodically while on treatment and to supplement with vitamin B6 as necessary
Key parameters of the second phase of analysis include: Study period: GLP-1 initiations between November 2021 and March 2025, with paid claims observed through June 2025
Choose low-mercury fish and minimize unnecessary sources of mercury exposure
Reduced risk of side effects GLP-1 medications can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and bloating